Self‐organization and polyolefin nucleation efficacy of 1,3:2,4‐di‐p‐methylbenzylidene sorbitol

TA Shepard, CR Delsorbo, RM Louth… - Journal of Polymer …, 1997 - Wiley Online Library
Recent studies have demonstrated that addition of a small quantity of dibenzylidene sorbitol
(DBS) to a molten polymer may result in a physical gel if conditions permit the DBS …

Estimation of area under the curve for drugs subject to enterohepatic cycling

TA Shepard, RH Reuning, LJ Aarons - Journal of pharmacokinetics and …, 1985 - Springer
Shepard was supported by a fellowship from the American Foundation for Pharmaceutical
Education. ICollege of Pharmacy, Ohio State University, Columbus, Ohio 43210. 2Department …

[PDF][PDF] Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling

TA Shepard, RH Reuning… - Journal of pharmaceutical …, 1985 - jupiter.chem.uoa.gr
It has been suggested in a recent publication that area under the plasma concentration-time
curve (AUC) is dependent on the extent of enterohepatic cycling (EHC), that the ratio of AUC …

Chloroform exposure and the body burden associated with swimming in chlorinated pools

CP Weisel, TA Shepard - Water contamination and health, 2020 - api.taylorfrancis.com
Chloroform in swimming pools disinfected with sodium hypochlorite has been demonstrated
to be at elevated levels compared with chlorinated drinking water. Typical chloroform …

Roadblocks to effective pain treatment

RL Stieg, P Lippe, TA Shepard - Medical Clinics of North America, 1999 - Elsevier
Despite the endless rhetoric about the need to demonstrate value in health care delivery and
the debatable sophistry that health care purchasers are truly becoming value oriented, the …

Mean residence time for drugs subject to enterohepatic cycling

TA Shepard, GF Lockwood, LJ Aarons… - … of pharmacokinetics and …, 1989 - Springer
Shepard and RH Reuning. An equation for the systemic availability of drugs undergoing
simultaneous enterohepatic cycling, first-pass metabolism, and intestinal elimination. Pharm. …

An equation for the systemic availability of drugs undergoing simultaneous enterohepatic cycling, first-pass metabolism, and intestinal elimination

TA Shepard, RH Reuning - Pharmaceutical research, 1987 - Springer
A relationship between systemic availability and its determinants has been derived for a
physiologically realistic model of drug disposition that includes enterohepatic cycling (EHC), …

Enterohepatic recirculation of the new antihypertensive drug UP 269-6 in humans. A possible model to account for multiple plasma peaks.

…, R Arnaud, S Saivin, TA Shepard… - Arzneimittel …, 1998 - europepmc.org
Following a single dose of a new antihypertensive drug, UP 269-6 (5-methyl-7-propyl-8-[(2'-(1H-tetrazol-5-yl)
biphenyl-4-yl) methyl]-1, 2, 4-triazolo [1, 5-c] pyrimidin-2 (3H)-one, CAS …

Digoxin and metabolites in urine and feces; a fluorescence derivatization—high-performance liquid chromatographic technique

TA Shepard, J Hui, A Chandrasekaran… - … of Chromatography B …, 1986 - Elsevier
A high-performance liquid chromatography method is described for the determination of
digoxin and its metabolites digoxigenin, digoxigenin monodigitoxoside, digoxigenin bis-…

Formation of [20R]-dihydrodigoxin from digoxin in humans.

RH Reuning, TA Shepard, BE Morrison… - Drug metabolism and …, 1985 - ASPET
The objective of this research was to determine the stereochemical identity of dihydrodigoxin
(DHD3), a metabolite of digoxin excreted in urine after digoxin administration in man. …